Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
INR 1806.5
(0.3%)
INR 1806.5
(0.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 484.96 Billion INR | 12.06% |
| 2022 | 432.78 Billion INR | 12.63% |
| 2021 | 384.26 Billion INR | 15.95% |
| 2020 | 331.39 Billion INR | 2.52% |
| 2019 | 323.25 Billion INR | 12.69% |
| 2018 | 286.86 Billion INR | 10.06% |
| 2017 | 260.64 Billion INR | -13.1% |
| 2016 | 299.93 Billion INR | 8.15% |
| 2015 | 277.32 Billion INR | 1.63% |
| 2014 | 272.86 Billion INR | 70.49% |
| 2013 | 160.04 Billion INR | 42.33% |
| 2012 | 112.44 Billion INR | 40.53% |
| 2011 | 80.01 Billion INR | 39.85% |
| 2010 | 57.21 Billion INR | 46.55% |
| 2009 | 39.03 Billion INR | -8.62% |
| 2008 | 42.72 Billion INR | 27.28% |
| 2007 | 33.56 Billion INR | 57.43% |
| 2006 | 21.32 Billion INR | 30.26% |
| 2005 | 16.36 Billion INR | 36.6% |
| 2004 | 11.98 Billion INR | 21.7% |
| 2003 | 9.84 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 126.52 Billion INR | 5.59% |
| 2024 Q2 | 132.64 Billion INR | 5.05% |
| 2023 Q4 | 119.82 Billion INR | -1.43% |
| 2023 Q3 | 121.56 Billion INR | 1.28% |
| 2023 Q2 | 120.03 Billion INR | 1.85% |
| 2023 Q1 | 117.85 Billion INR | 9.88% |
| 2023 FY | 484.96 Billion INR | 12.06% |
| 2022 FY | 432.78 Billion INR | 12.63% |
| 2022 Q4 | 107.25 Billion INR | -3.37% |
| 2022 Q2 | 108.09 Billion INR | 1.55% |
| 2022 Q1 | 106.43 Billion INR | 13.4% |
| 2022 Q3 | 111 Billion INR | 2.69% |
| 2021 Q4 | 93.86 Billion INR | -4.36% |
| 2021 FY | 384.26 Billion INR | 15.95% |
| 2021 Q1 | 96.69 Billion INR | 14.68% |
| 2021 Q2 | 95.56 Billion INR | -1.17% |
| 2021 Q3 | 98.14 Billion INR | 2.69% |
| 2020 FY | 331.39 Billion INR | 2.52% |
| 2020 Q4 | 84.31 Billion INR | -3.99% |
| 2020 Q3 | 87.81 Billion INR | 3.82% |
| 2020 Q2 | 84.58 Billion INR | 13.28% |
| 2020 Q1 | 74.67 Billion INR | -7.56% |
| 2019 Q1 | 82.59 Billion INR | 17.25% |
| 2019 Q2 | 79.49 Billion INR | -3.75% |
| 2019 FY | 323.25 Billion INR | 12.69% |
| 2019 Q3 | 80.38 Billion INR | 1.13% |
| 2019 Q4 | 80.78 Billion INR | 0.49% |
| 2018 Q2 | 68.46 Billion INR | -4.1% |
| 2018 FY | 286.86 Billion INR | 10.06% |
| 2018 Q4 | 70.44 Billion INR | -8.0% |
| 2018 Q3 | 76.56 Billion INR | 11.83% |
| 2018 Q1 | 71.38 Billion INR | 6.37% |
| 2017 Q1 | 61.66 Billion INR | -9.65% |
| 2017 FY | 260.64 Billion INR | -13.1% |
| 2017 Q4 | 67.11 Billion INR | 1.71% |
| 2017 Q3 | 65.98 Billion INR | 0.12% |
| 2017 Q2 | 65.9 Billion INR | 6.87% |
| 2016 Q1 | 80.06 Billion INR | 8.0% |
| 2016 FY | 299.93 Billion INR | 8.15% |
| 2016 Q4 | 68.25 Billion INR | -11.17% |
| 2016 Q3 | 76.83 Billion INR | -1.04% |
| 2016 Q2 | 77.64 Billion INR | -3.03% |
| 2015 Q2 | 68.03 Billion INR | 4.31% |
| 2015 Q3 | 70.46 Billion INR | 3.58% |
| 2015 Q1 | 65.22 Billion INR | 6.92% |
| 2015 Q4 | 74.13 Billion INR | 5.21% |
| 2015 FY | 277.32 Billion INR | 1.63% |
| 2014 Q4 | 61 Billion INR | 42.54% |
| 2014 Q2 | 47.5 Billion INR | 20.98% |
| 2014 Q1 | 39.26 Billion INR | -2.89% |
| 2014 FY | 272.86 Billion INR | 70.49% |
| 2014 Q3 | 42.79 Billion INR | -9.91% |
| 2013 Q1 | 34.82 Billion INR | 13.16% |
| 2013 Q2 | 41.92 Billion INR | 20.39% |
| 2013 Q3 | 42.86 Billion INR | 2.26% |
| 2013 Q4 | 40.43 Billion INR | -5.67% |
| 2013 FY | 160.04 Billion INR | 42.33% |
| 2012 Q1 | 26.58 Billion INR | 14.28% |
| 2012 Q3 | 28.52 Billion INR | 7.33% |
| 2012 Q4 | 30.77 Billion INR | 7.89% |
| 2012 FY | 112.44 Billion INR | 40.53% |
| 2012 Q2 | 26.57 Billion INR | -0.03% |
| 2011 Q4 | 23.25 Billion INR | 8.43% |
| 2011 Q3 | 21.45 Billion INR | 13.22% |
| 2011 Q2 | 18.94 Billion INR | 15.83% |
| 2011 Q1 | 16.35 Billion INR | 0.0% |
| 2011 FY | 80.01 Billion INR | 39.85% |
| 2010 FY | 57.21 Billion INR | 46.55% |
| 2009 FY | 39.03 Billion INR | -8.62% |
| 2008 FY | 42.72 Billion INR | 27.28% |
| 2007 FY | 33.56 Billion INR | 57.43% |
| 2006 FY | 21.32 Billion INR | 30.26% |
| 2005 FY | 16.36 Billion INR | 36.6% |
| 2004 FY | 11.98 Billion INR | 21.7% |
| 2003 FY | 9.84 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sigachi Industries Limited | 3.98 Billion INR | -12055.936% |
| Ind-Swift Limited | 5.02 Billion INR | -9551.727% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -10143.983% |
| Sakar Healthcare Limited | 1.54 Billion INR | -31357.287% |
| Aurobindo Pharma Limited | 290.01 Billion INR | -67.22% |
| Innova Captab Limited | 10.81 Billion INR | -4385.03% |
| Divi's Laboratories Limited | 78.45 Billion INR | -518.188% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -3643.398% |
| Morepen Laboratories Limited | 17.01 Billion INR | -2749.572% |
| Mankind Pharma Limited | 103.34 Billion INR | -369.259% |
| Sequent Scientific Limited | 13.69 Billion INR | -3440.611% |
| Wanbury Limited | 5.75 Billion INR | -8324.714% |
| Laurus Labs Limited | 50.01 Billion INR | -869.588% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -2778.884% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -2024.061% |
| Alembic Limited | 1.57 Billion INR | -30694.525% |
| Hikal Limited | 17.84 Billion INR | -2617.519% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -693.455% |
| Neuland Laboratories Limited | 15.58 Billion INR | -3011.604% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -1306.655% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | -310.535% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -2173.869% |
| Themis Medicare Limited | 3.81 Billion INR | -12603.465% |
| RPG Life Sciences Limited | 5.82 Billion INR | -8232.076% |
| Zydus Lifesciences Limited | 190.21 Billion INR | -154.958% |
| Lupin Limited | 196.56 Billion INR | -146.724% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -11413.138% |
| Wockhardt Limited | 27.89 Billion INR | -1638.862% |
| Vaishali Pharma Limited | 862.79 Million INR | -56108.876% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -2571.259% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -23137.367% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -623.52% |
| FDC Limited | 19.42 Billion INR | -2396.05% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | -73.722% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -31315.472% |
| Eris Lifesciences Limited | 20.09 Billion INR | -2313.808% |
| Venus Remedies Limited | 5.91 Billion INR | -8099.659% |
| ZIM Laboratories Limited | 3.67 Billion INR | -13095.811% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -6196.29% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -50607.494% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -2792.261% |
| Shilpa Medicare Limited | 11.53 Billion INR | -4105.756% |
| Albert David Limited | 3.62 Billion INR | -13279.855% |
| Ajanta Pharma Limited | 42.08 Billion INR | -1052.297% |
| Hester Biosciences Limited | 3.04 Billion INR | -15824.31% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -4512.801% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -3816.121% |
| Gufic Biosciences Limited | 8.06 Billion INR | -5912.013% |
| Windlas Biotech Limited | 6.3 Billion INR | -7586.249% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -4112.502% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -12158.508% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -13101.681% |
| Granules India Limited | 45.06 Billion INR | -976.185% |
| Aarti Drugs Limited | 25.28 Billion INR | -1817.951% |
| Bal Pharma Limited | 3.39 Billion INR | -14196.594% |
| Alkem Laboratories Limited | 126.67 Billion INR | -282.842% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -8253.61% |
| Medicamen Biotech Limited | 1.79 Billion INR | -26946.945% |
| Unichem Laboratories Limited | 16.57 Billion INR | -2826.052% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -31708.367% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -121035.223% |
| Valiant Laboratories Limited | 1.82 Billion INR | -26538.249% |
| Orchid Pharma Limited | 8.19 Billion INR | -5818.81% |
| Medico Remedies Limited | 1.44 Billion INR | -33364.405% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -3686.155% |
| Ipca Laboratories Limited | 77.05 Billion INR | -529.349% |
| Brooks Laboratories Limited | 794.86 Million INR | -60912.995% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -18607.029% |
| Piramal Enterprises Limited | 60.33 Billion INR | -703.762% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -357.283% |
| NATCO Pharma Limited | 40.02 Billion INR | -1111.815% |
| Suven Life Sciences Limited | 116.92 Million INR | -414654.68% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -96082.878% |
| Strides Pharma Science Limited | 40.51 Billion INR | -1097.121% |
| Indoco Remedies Limited | 18.17 Billion INR | -2568.636% |
| Alpa Laboratories Limited | 1.08 Billion INR | -44499.316% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -46381.861% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -64095.721% |